Charles Thomas, Karen Mullis & Phillip Johnson from the June 1994 issue
(Page 3 of 3)
An audit of the CDC statistics to remove HIV bias and thereby allow unprejudiced testing of the critical epidemiological evidence for the theory. Every effort should be made to determine how many AIDS patients were actually tested for antibodies and the testing method that was employed. Because even the most reliable antibody test generates many false-positive results, researchers should try to validate the tests by examining random samples of AIDS patients to determine whether significant amounts of replicating HIV can be found in their bodies. Statistics have been kept as if the purpose were to protect the HIV theory rather than to learn the truth.
Research focusing on the cause of particular diseases rather than the politically defined hodgepodge of diseases we now call AIDS. The cancer-like skin disease called Kaposi's sarcoma (KS) is one of the best-known AIDS-defining conditions, but leading KS and HIV experts Marcus Conant and Robin Weiss now say that dozens of non-HIV KS cases are under study in the United States and that KS is becoming much less frequent in gay male AIDS patients than it formerly was. Conant, Weiss, and other AIDS researchers now frankly attribute KS to an "unknown infectious agent" rather than to HIV, but KS is nonetheless still called AIDS when it occurs in combination with HIV. Duesberg attributes KS in gay males to the use of amyl nitrates (poppers) as a sexual stimulant. His theory is eminently testable, and it ought to be given a fair chance. Another example: Hemophiliacs in the age of AIDS are living longer than they ever did in the past, but they still often die of conditions related to receipt of the blood concentrate called Factor VIII. Research published in The Lancet in February confirms earlier reports that symptoms diagnosed as AIDS are best treated by providing a highly purified form of Factor VIII. Researchers should study the role of blood-product impurities in causing disease in hemophiliacs, without the distortion that comes from arbitrarily assuming that HIV is responsible whenever an HIV-positive hemophiliac becomes ill.
A critical re-examination of the statistics for AIDS and HIV in Africa and Asia. Researchers should perform new, controlled studies of representative African populations to test the relationship of confirmed HIV infection to the incidence of AIDS-defining diseases. It will not do to rely upon "presumptive diagnoses" or extrapolations from single antibody tests that are now well known to generate many false positives.
The HIV establishment and its journalist allies have replied to various specific criticisms of the HIV theory without taking them seriously. They have never provided an authoritative paper that undertakes to prove that HIV really is the cause of AIDS--meaning a paper that does not start by assuming the point at issue. The HIV theory was established as fact by Robert Gallo's official press conference in 1984, before any papers were published in American journals. Thereafter the research agenda was set in concrete, and skeptics were treated as enemies to be ignored or punished. As a result, the self-correcting processes of science have broken down, and journalists have not known how to ask the hard questions. After 10 yearsof failure, it is time to take a second look.
Charles A. Thomas, a biochemist, is president of the Helicon Foundation in San Diego and secretary of the Group for the Scientific Reappraisal of the HIV/AIDS Hypothesis. Kary B. Mullis is the 1993 Nobel Prize winner in chemistry for his invention of the polymerase chain reaction technique, for detecting DNA, which is used to search for fragments of HIV in AIDS patients. Phillip E. Johnson is the Jefferson E. Peyser Professor of Law at the University of California, Berkeley.
Help Reason celebrate its next 40 years. Donate Now!
Try Reason's award-winning print edition today! Your first issue is FREE if you are not completely satisfied.
Site comments/questions:
Media Inquiries and Reprint Permissions:
(310) 367-6109
Editorial & Production Offices:
3415 S. Sepulveda Blvd.
Suite 400
Los Angeles, CA 90034
(310) 391-2245